Lecture 2 Esophagus

63
LECTURE 2 DISORDERS OF THE ESOPHAGUS ESOPHAGEAL FUNCTION INSERTION BY HYPOPHARYNX & INSERTION BY HYPOPHARYNX & RELAXATION OF THE UPPER ESOPHAGEAL SPHINCTER (UES) TRANSPORT BY ESOPHAGEAL PERISTALSIS DELIVERY BY PERISTALSIS AND RELAXATION OF THE LOWER ESOPHAGEAL SPHINCTER (LES) LES pressure is about 15 mmHg above intragastric pressure

Transcript of Lecture 2 Esophagus

  • LECTURE 2

    DISORDERS OF THE ESOPHAGUS

    ESOPHAGEAL FUNCTION

    INSERTION BY HYPOPHARYNX & INSERTION BY HYPOPHARYNX & RELAXATION OF THE UPPER ESOPHAGEAL SPHINCTER (UES) TRANSPORT BY ESOPHAGEAL PERISTALSIS DELIVERY BY PERISTALSIS AND RELAXATION OF THE LOWER ESOPHAGEAL SPHINCTER (LES)

    LES pressure is about 15 mmHg above intragastric pre ssure

  • 59-y.o. male

    History of chest pain Intermittent heartburn Intermittent dysphagia Normal exam Labs: normal Normal cardiac evaluation

  • CASE

    UPPER ENDOSCOPY: EROSIVE ESOPHAGITIS ESOPHAGEAL

    STRICTURE

    TREATMENT ESOPHAGEAL DILATION HEALTH HABITS and

    DIETARY PRECAUTIONS PROTON PUMP INHIBITOR

  • ESOPHAGEAL SYMPTOMS HEARTBURN DYSPHAGIA

    OROPHARYNGEAL 32 muscles involved with swallowing

    ESOPHAGEAL NEUROMUSCULAR DYSFUNCTION NEUROMUSCULAR DYSFUNCTION MECHANICAL

    REGURGITATION CHEST PAIN ODYNOPHAGIA PSEUDOPHAGIA GLOBUS

  • GASTROESOPHAGEAL REFLUX DISEASE (GERD)

    PATHOPHYSIOLOGY: REFLUXATE OVERCOMES THE ANTIREFLUX BARRIERS OF THE

    GASTROESOPHAGEAL JUNCTION (LES @ GEJ)

    INAPPROPRIATE, PATHOLOGIC, SPONTANEOUS TRANSIENT RELAXATION OF THE LOWER ESOPHAGEAL SPHINCTER

    REDUCED LES PRESSURE INCREASED ABDOMINAL PRESSURE

    OBESITY PREGNANCY

    INCREASED NOCTURNAL HCL (EATING LATE )

  • GERD PATHOPHYSIOLOGY

    INCREASED ESOPHAGEAL:HCL (acid) CONTACT (at night) WITH DECREASED CLEARING OF REFLUXATE

    DELAYED GASTRIC EMPTYING HIATAL HERNIA (sliding) HIATAL HERNIA (sliding)

    TRANSIENT RELAXATION OF THE LES IMPAIRED LES FUNCTION

    SMOKING, ALCOHOL, CAFFEINE, CHOCOLATE NEGATIVE H. PYLORI STATUS

    POSITIVE H. pylori STATUS IS PROTECTIVE EMOTIONAL STRESS

    INCREASES SUBJECTIVE SEVERITY OF REFLUX SYMPTOMS BUT NOT THE NUMBER OR DURATION OF REFLUX EVENTS

  • LESP & HIATAL HERNIA GERD

    Size of Hiatal Hernia

  • HIATAL HERNIASLIDING

  • PROGRESSIVELY INCREASING LAXITY OF THE PHRENOESOPHA GEAL MEMBRANE, , LEADING TO HIATAL HERNIA AND GROSS INCOMPETENCE

  • HIATAL HERNIA PARAESOPHAGEAL

    MOST (SMALL) AREASYMPTOMATIC

    LARGER PARAESOPHAGEALHERNIA CAN CAUSE:EPIGASTRIC PAINEPIGASTRIC PAINNAUSEA/VOMITINGGASTRIC OBSTRUCTIONBLEEDINGPERFORATIONGASTRIC VOLVULUS

    REQUIRE SURGICALREPAIR

  • PULMONARYGERD NOT A COMMON CAUSE OF THESE

    CONDITIONS

    ASTHMA CHRONIC BRONCHITIS ATELECTASIS ATELECTASIS PULMONARY FIBROSIS CHRONIC COUGH

  • EAR-NOSE-THROATGERD NOT A COMMON CAUSE OF THESE

    CONDITIONS:

    THROAT CLEARING CHRONIC HOARSENESS DENTAL DISEASE HALITOSIS HALITOSIS NOCTURNAL CHOKING GLOBUS VOCAL CORD ULCERS SUBGLOTTIC STENOSIS PHARYNGITIS NAUSEA

  • DIAGNOSIS GERD

    HISTORY - SYMPTOMS UGI SERIES (BARIUM)

    DEMONSTRATE REFLUX INSENSITIVE INSENSITIVE

    UPPER ENDOSCOPY NORMAL (NERD) ESOPHAGITIS BARRETTS ESOPHAGUS EVALUATE AND TREAT

    COMPLICATIONS

  • WHEN TO DO ENDOSCOPY ?ALARM SYMPTOMS

    DYSPHAGIA GI BLEEDING ANEMIA WEIGHT LOSS WEIGHT LOSS INADEQUATE THERAPEUTIC

    RESPONSE POSSIBLE BARRETTS ESOPHAGUS

    with LONG HISTORY OF UNDER TREATED GERD, SYMPTOMS > 5 YRS although there is questionable benefit with routine screening

  • OTHER DIAGNOSTIC TESTS ESOPHAGEAL MOTILITY

    POSITION pH PROBE EVALUATE ESOPHAGEAL FUNCTION

    BEFORE SURGERY

    24-hour pH STUDY WHEN DIAGNOSIS IS IN DOUBT NON RESPONSE TO THERAPY

    ESOPHAGEAL IMPEDANCE MEASURES REFLUX; ACID AND

    NONACID REFLUX

  • ESOPHAGTITIS

  • ESOPHAGEAL STRICTURE

  • THERAPY GERD IS CHRONIC & RECURRENT

    THERAPY IS LONG TERM IN MODERATE TO SEVERE DISEASE

    DIET AND HEALTH HABITS ELEVATION - HEAD OF THE BED

    (NIGHTTIME SYMPTOMS)(NIGHTTIME SYMPTOMS) TITRATE TO DISEASE SEVERITY

    PPIs when ALARM SYMPTOMS PRESENT STEP UP THERAPY

    UNTIL CONTROLLED

    STEP DOWN THERAPY UNTIL BREAK-THROUGH

  • H-2 BLOCKERS

    CIMETIDINE (TAGAMET) RANITIDINE (ZANTAC) FAMOTIDINE (PEPCID) FAMOTIDINE (PEPCID) NIZATIDINE (AXID)

  • PROTON PUMP INHIBITORS

    OMEPRAZOLE (PRILOSEC)* LANSOPRAZOLE (PREVACID, DEXILANT) REBEPRAZOLE (ACIPHEX) PANTOPRAZOLE (PROTONIX) PANTOPRAZOLE (PROTONIX) ESOMEPRAZOLE (NEXIUM)** OMEPRAZOLE + Na Bicarb

    IMMEDIATE RELEASE (ZEGERID)

  • LIMITATIONS OF PPI TREATMENT GERD

    SPECIFIC GERD Sx ARE NOT EQUALLY RESPONSIVE Heartburn > Regurgitation > Chest pain > Cough

    NO SYMPTOM IS 100% SPECIFIC FOR GERD Nonresponsive to treatment make sure there is refl ux

    24 hour pH monitoring or Esophageal impedance testi ng 24 hour pH monitoring or Esophageal impedance testi ng

    HYPERSENSITIVITY PPIs do not directly treat GERD; it is a neuromuscu lar

    dysfunctional disorder that leads to pathological r eflux

  • TYPICAL GERD SYMPTOMS

    ALARM SX / SIGNS PRESENTDYSPHAGIAFOOD IMPACTIONWEIGHT LOSSGI BLEEDINGANEMIAADVANCED AGE (>50)FAMILY HX OF UGI CANCERODYNOPHAGIA

    ALARM SX / SIGNS ABSENT

    LIFESTYLE CHANGESOTC AA or H2RA prn

    PERSISTENT SXSNO

    CONTINUE RX

    YESUPPER ENDOSCOPY

    H2RA BID or PPI QD

    YES

    PERSISTENT SXS

    CONTINUE TX, DECREASING TOLOWEST EFFECTIVE ACID SUPPRESSION TO CONTROL SXS

    NO

    UPPER ENDOSCOPY

    YES

    EROSIVE ESOPHAGITISESOPHAGEAL ULCERBARRETTS ESOPHAGUSNORMAL

    PPI BID or for NORMAL QD

    PERSISTENT SXS

    24-HOUR pH or IMPEDANCE STUDY ANTIREFLUX PROCEDURE

    NO

    YES REFLUX CONFIRMED

    CANCERDYSPHAGIAWT LOSS

    EOSINOPHILIC ESOPHAGITIS

  • COMPLICATIONSGERD

    STRICTURE - DYSPHAGIA ULCER PAIN, BLEEDING INTRACTABLE

    TROUBLESOME SYMPTOMS TROUBLESOME SYMPTOMS MICROASPIRATION BARRETTS ESOPHAGUS

  • BARRETTS ESOPHAGUSSPECIALIZED INTESTINAL METAPLASIA IN THE

    DISTAL ESOPHAGUS1.7% OF ADULT POPULATION IN US

    CHRONIC SEVERE REFLUX of both Acid and Bile salts a nd esophageal exposure time

    ENDOSCOPY AND BIOPSIES STRICTURE (MID-ESOPHAGUS) STRICTURE (MID-ESOPHAGUS) RISK FOR PROGRESSION TO CANCER

    LARGE HIATAL HERNIA LONG BARRETTS SEGMENT DYSPLASIA (high grade) MALES > FEMALES AGE > 70 SMOKING

    ADENOCARCINOMA RISK ~ 0.3% /year

    1/3 OF PATIENTS ARE ACID INSENSITIVE

  • BARRETTS ESOPHAGUS

  • BARRETTS ESOPHAGUS ULCER

  • ESOPHAGEAL STRICTURE BARRETTS ESOPHAGUS

  • 63-year-old male presents with a history of

    progressive dysphagia

    Dysphagia associated with a 15 lb weight loss over the last 3 months

    Has to eat softer food to get it to go down 40 year history of smoking 1 pack of cigarettes/day Exam: height was 70 inches and he weighed 155 lbs Exam: height was 70 inches and he weighed 155 lbs

    (weight 6 months ago 170 lbs) The remainder of the examination was normal except

    for reduced breath sounds on chest exam

    WHAT IS THE MOST LIKELY CAUSE OF THIS PATIENT S DYSPHAGIA?

  • Downloaded from: Gastrointestinal and Liver Disease 8e (on 24 September 2006 03:28 PM)

    2005 Elsevier

    GERD EoE

  • OBSTRUCTIVE LESIONSDYSPHAGIA

    CARCINOMA DYSPHAGIA with WEIGHT LOSS SQUAMOUS CELL CARCINOMA

    ALCOHOL AND SMOKING ALCOHOL AND SMOKING

    ADENOCARCINOMA GASTROESOPHAGEAL REFLUX DISEASE

    ALSOLUTE RISK IS LOW< 10,000 CASES/YEAR IN USINCIDENCE IS INCREASING

  • ESOPHAGEAL ADENOCARCINOMA PATHOGENESIS

    GERD CHRONIC ESOPHAGITIS INTESTINAL METAPLASIA INTESTINAL METAPLASIA

    (BARRETTS)* (ALL CASES?)DYSPLASIA ADENOCARCINOMA

    Enzinger, PC and Mayer, RJ; Medical Progress: Esop hageal Cancer. NEJM; 2003, 349:2241-2252

  • TNM STAGING ESOPHAGEAL CANCER

    CT CHEST / UPPER ABDOMEN / ENDOSCOPIC ULTRASOUND

    PRIMARY TUMOR (T 1 - 4) REGIONAL LYMPH NODES (N0, N1) DISTANT METASTASIS (M0, M1) T1 OR T2, NO, MO - CURATIVE SURGERY T4 OR M1 - CHEMORADIATION T2 OR T3, N1 - CHEMORADIATION +/-

    SURGERY

  • ESOPHAGOGASTRECTOMYCANCER OF THE DISTAL ESOPHAGUS

    5-YEAR SURVIVAL: 20-25%

  • ESOPHAGEAL CANCERADENOCARCINOMA

  • ESOPHAGEAL CANCER SQUAMOUS CELL

    OBSTRUCTIVE DYSPHAGIAALCOHOL & SMOKING

  • ESOPHAGEAL CANCER SQUAMOUS CELL

    RADIOGRAPHIC APPEARANCE

  • ESOPHAGEAL CANCER ADENOCARCINOMA

  • 26-year-old male dysphagia associated with an

    esophageal food impaction

    Occurred while eating chicken History of intermittent heartburn and on occasion d ysphagia

    over the last 3 years. The heartburn has not been helped with the use of r anitidine The patient was thin otherwise the examination was normal

    Labs including a CBC were normal Labs including a CBC were normal

    WHAT DOES IMPACTION SUGGEST?

    WHAT ARE THE POSSIBLE CAUSES OF THE DYSPHAGIA?

    HOW SHOULD THIS PATIENT BE EVALUATED?

  • MEAT (CHICKEN) IMPACTION IMPACTION REMOVED

    EOSINOPHILIC ESOPHAGTITIS

  • EOSINOPHILIC ESOPHAGITIS (EoE ) AFFECTS ALL AGE GROUPS including children MEN > WOMEN SHARES CLINICAL and HISTOLOGIC FEATURES with GERD

    CHILDREN: vomiting, feeding intolerance, failure to thrive ADULTS: chest pain, heartburn, epigastric pain, dysp hagia, food

    impactions, refractory GERD

    EoE AND GERD ARE NOT MUTUALLY EXCLUSIVE PPI-responsive EoE (do not have GERD) exhibit a clinical PPI-responsive EoE (do not have GERD) exhibit a clinical

    response to PPIs PPI may have an anti-inflammatory effect

    TREATMENT of SUSPECTED EoE: Trial of PPI for 2 months Swallowed topical steroids Empiric elimination diets Esophageal dilation for dysphagia

  • EOSINOPHILIC ESOPHAGITISFOOD ALLERGY or AEROALLERGEN

    ANTIGEN

    ACTIVATED IMMUNE SYSTEM

    Th2 (IL-4, IL-5, IL-13)

    EOTAXIN-3 secretion from the esophageal

    squamous cells

    Eosinophilshome to the esophagus

    Omeprazole blocks IL-13 Induced Eotaxin-3 secretionIn sq. cells from EoE patients

  • 69-YEAR OLD MALE PRESENTS TO THE EMERGENCY DEPARTMENT AT 11:00 PM WITH THE INABILITY TO

    SWALLOW HIS OWN SALIVA

    He was eating a steak at 7:00 pm which lodged in his throat

    Has been unable to swallow since that time Normally has no difficulty eating, but has noted tha t Normally has no difficulty eating, but has noted tha t

    meat has had a tendency to hang-up on occasion. Except for drooling the exam was normal

    WHAT IS THE CAUSE OF THIS PATIENT S DYSPHAGIA?HOW SHOULD THIS PROBLEM BE EVALUATED AND TREATED?

  • Downloaded from: Gastrointestinal and Liver Disease 8e (on 24 September 2006 03:28 PM)

    2005 Elsevier

    GERDEoE

  • OBSTRUCTIVE LESIONSRINGS

    SCHATZKIS RING 10% OF POPULATION LUMEN < 13 mm: DYSPHAGIA LUMEN < 13 mm: DYSPHAGIA

    14-18 mm MAY HAVE DYSPHAGIA

  • SCHATZKIS RING

  • FOOD IMPACTION SCHATZKIS RING

    RELATED TO GERD

  • 55-YEAR OLD MALE WHO HAS A HISTORY OF PROGRESSIVE DYSPHAGIA TO BOTH

    LIQUIDS AND SOLIDS

    15 lbs loss over the last 6 months Notes regurgitation but not heartburn. He tried

    Prilosec but it was not helpful The patient was somewhat thin but the

    examination was otherwise normal Labs including a CBC were normalPOSSIBLE CAUSES OF THIS PATIENT S DYSPHAGIA?

  • Downloaded from: Gastrointestinal and Liver Disease 8e (on 24 September 2006 03:28 PM)

    2005 Elsevier

    GERDEoE

  • ESOPHAGEAL NEUROMUSCULAR (MOTILITY)

    DISORDERS

    ACHALASIA SCLERODERMA SCLERODERMA MOTILITY DISORDERS

    DISTAL (DIFFUSE) ESOPHAGEAL SPASM

    HYPOMOTILITY

  • ACHALASIAFAILURE TO RELAX

    DEGENERATION OF NEURONS (MYENTERIC PLEXUS) NITRIC OXIDE NEURONS

    (INHIBITION)(INHIBITION) VIP NEURONS

    REDUCED RELAXATION of the LES WITH SWALLOWING INCREASED LES PRESSURE

    LOSS OF PERISTALSIS IN THE LOWER 2/3 OF THE ESOPHAGUS

  • ACHALASIA

    DYSPHAGIA TO BOTH LIQUIDS AND SOLIDS

    WEIGHT LOSS ASPIRATION ASPIRATION INCREASED RISK OF SQUAMOUS

    CARCINOMA AFTER AGE 50 IF UNTREATED

  • ACHALASIA DIAGNOSIS

    UPPER ENDOSCOPY ESOPHAGEAL MOTILITY STUDY

    TREATMENT PNEUMATIC BALLOON DILATION PNEUMATIC BALLOON DILATION SURGICAL MYOTOMY BOTOX INJECTION MEDICATION NOT VERY USEFUL

    NITRATES CALCIUM CHANNEL BLOCKER VIAGRA

  • ACHALASIA

    BIRDS BEAK ENDOSCOPIC VIEW

  • ACHALASIA PNEUMATIC BALLOON DILATION

  • 19-YEAR OLD FEMALE COMPLAINS OF

    ODYNOPHAGIA

    She has a history of acne for which she takes doxycycline which she typically takes at night

    She woke up in the morning with severe odynophagia when she drank a glass of orange juice. juice.

    Examination was normal. Labs including a CBC were normal

    WHAT IS THE MOST LIKELY CAUSE OF THIS PATIENT S ODYNOPHAGIA?

  • PILL ESOPHAGITIS ODYNOPHAGIA

  • ESOPHAGEAL INFLAMMATORY LESIONS

    EOSINOPHILIC ESOPHAGITIS PILL ESOPHAGITIS CANDIDA ESOPHAGITIS HERPETIC ESOPHAGITIS HERPETIC ESOPHAGITIS IDIOPATHIC ULCER - AIDS

    CANDIDA CMV HERPES

  • CANDIDA ESOPHAGITIS ODYNOPHAGIA

  • HERPETIC ESOPHAGITIS ODYNOPHAGIA

  • IDIOPATHIC ULCER - AIDS ODYNOPHAGIA

  • ESOPHAGEAL DISORDERS KEY POINTS

    GERD COMMON, RECURRENT, CHRONIC WIDE SPECTRUM OF SYMPTOMS TAILOR THERAPY TO SEVERITY STRICTURES 10%

    EXCLUDE CARDIAC CAUSES OF CHEST PAIN PRIOR TO CONSI DERING THE DIAGNOSIS OF NON-CARDIAC CHEST PAIN

    ALARM SYMPTOMS WARRANT UPPER ENDOSCOPY PPIs ARE EFFECTIVE AND SAFE FOR APPROPRIATE INDICAT IONS AND USING

    LOWEST EFFECTIVE DOSELOWEST EFFECTIVE DOSE ESOPHAGEAL ADENOCARCINOMA IS ON THE RISE (OBESITY, LONG HISTORY OF

    GERD, BARRETTS ESOPHAGUS) SQUAMOUS CELL CARCINOMA RELATED TO TOBACCO AND ALCO HOL USE

    (DECREASING) ACUTE ODYNOPHAGIA - PILL ESOPHAGITIS INFLAMMATORY ESOPHAGITIS

    EOSINOPHILIC ESOPHAGITIS (CHILDREN, ADULTS MALE > FEMALE) SHARES SYMPTOMS WITH GERD ENDOSCOPY WITH BIOPSIES PPI, TOPICAL STEROID, ELIMINATION DIET

    HEALTHY PEOPLE: HSV AIDS, DM, CHEMO: CANDIDA, CMV, HSV, IEU (AIDS)

    SCHATZKIS RINGS INTERMITTENT DYSPHAGIA

  • LARGE ESOPHAGEAL ULCER WITH TRACHEOESOPHAGEAL FISTU LA

    ESOPHAGEAL STENT PLACED

    TRACHEOESOPHAGEAL FISTULA